0.3% Tacrolimus Gel and 0.5% Tacrolimus Cream Show Efficacy in Mild to Moderate Plaque Psoriasis: Results of a Randomized, Open-label, Observer-blinded Study

By Ortonne Jean-Paul   van de Kerkhof Peter C. M.   Prinz Jörg C.   Bieber Thomas   Lahfa Morad   Rubins Andris   Wozel Gottfried      

Acta Dermato-Venereologica, Vol. 86, Iss. 1, 2006-01 ,pp. : 29-33

Medical Journals Limited

Access to resources Recommend Favorite

Combined treatment with low-dose cyclosporine and calcipotriol/betamethasone dipropionate ointment for moderate-to-severe plaque psoriasis: a randomized controlled open-label study

By Vena Gino A.   Galluccio Antonia   Pezza Michele   Vestita Michelangelo   Cassano Nicoletta  

Journal of Dermatological Treatment, Vol. 23, Iss. 4, 2012-08 ,pp. : 255-260

Informa Healthcare

Access to resources Recommend Favorite

An open-label pilot study to evaluate the safety and efficacy of topically applied tacrolimus ointment for the treatment of hand and/or foot eczema

By Thelmo MC   Lang Wei   Brooke E   Osborne BE   McCarty MA   Jorizzo JL   Fleischer   Jr. Alan  

Journal of Dermatological Treatment, Vol. 14, Iss. 3, 2003-09 ,pp. : 136-140

Informa Healthcare

Access to resources Recommend Favorite

An open-label pilot study to evaluate the efficacy and tolerability of a silicone gel in the treatment of hypertrophic scars using clinical and ultrasound assessments

By Lacarrubba Francesco   Patania Lara   Perrotta Rosario   Stracuzzi Giorgio   Nasca Maria Rita   Micali Giuseppe  

Journal of Dermatological Treatment, Vol. 19, Iss. 1, 2008-01 ,pp. : 50-53

Informa Healthcare

Access to resources Recommend Favorite

Ustekinumab in nail psoriasis: an open-label, uncontrolled, nonrandomized study

By Patsatsi Aikaterini   Kyriakou Aikaterini   Sotiriadis Dimitrios  

Journal of Dermatological Treatment, Vol. 24, Iss. 2, 2013-04 ,pp. : 96-100

Informa Healthcare

Access to resources Recommend Favorite